About this trial

The study aims at comparing, in a large cohort of consecutive clinically indicated left atrial appendage closure, clinical and imaging outcomes between different subpopulations.

Eligibility criteria

Qualifiers

Age> 18

Written informed consent to participate in the study

Patients with paroxysmal, persistent, or permanent non-valvular AF and CHA2DS2-VASc Score of ≥2 that are planned for an elective LAA-closure

Anatomic characteristics allow placement of a CE marked device, dedicated for LAAC

Disqualifiers

None. Considering the nature of the project, which is to prospectively collect information on all patients treated with LAAC in our center, we will only exclude patients unwilling to sign the informed consent.

Trial design

Treatments tested in this trial

  • Use of echocardiography guidance for LAAC

Treatment groups

No treatment groups listed

Locations

1
Bern University Hospital Inselspital3010, Bern Switzerland

Sponsors and collaborators

Insel Gruppe AG, University Hospital Bern

Lead sponsor